|
Augmentin 625mg tablets
Amoxicilin + acid clavulanic
- Strength / route
- 500mg + 125mg · Oral
- Qty
- 14,000 Tablet
- Total
- 167,104,000
- Group
- N1
- Manufacturer
- SmithKline Beecham Limited (Anh)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-20169-16 |
500mg + 125mg
Oral
|
Tablet |
14,000
|
11,936
|
167,104,000
|
N1 |
SmithKline Beecham Limited
Anh
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Augmentin 625mg tablets
Amoxicilin + acid clavulanic
- Strength / route
- 500mg + 125mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- SmithKline Beecham Limited (Anh)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-20169-16 |
500mg + 125mg
Oral
|
Tablet |
0
|
11,936
|
0
|
N1 |
SmithKline Beecham Limited
Anh
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Avamys
Fluticasone furoate
- Strength / route
- 27.5 mcg/ dose xit · Nasal spray
- Qty
- 600 Canister
- Total
- 111,208,800
- Group
- N1
- Manufacturer
- Glaxo Operations (UK) Ltd. (trading as Glaxo Wellcome Operations) (Anh)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-21418-18 |
27.5 mcg/ dose xit
Nasal spray
|
Canister |
600
|
185,348
|
111,208,800
|
N1 |
Glaxo Operations (UK) Ltd. (trading as Glaxo Wellcome Operations)
Anh
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Avamys
Fluticasone furoate
- Strength / route
- 27.5 mcg/ dose xit · Nasal spray
- Qty
- 0 Canister
- Total
- 0
- Group
- N1
- Manufacturer
- Glaxo Operations (UK) Ltd. (trading as Glaxo Wellcome Operations) (Anh)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-21418-18 |
27.5 mcg/ dose xit
Nasal spray
|
Canister |
0
|
185,348
|
0
|
N1 |
Glaxo Operations (UK) Ltd. (trading as Glaxo Wellcome Operations)
Anh
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Avodart
Dutasterid
- Strength / route
- 0,5mg · Oral
- Qty
- 900 Tablet
- Total
- 15,531,300
- Group
- N1
- Manufacturer
- Delpharm Poznań S.A. (Ba Lan)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-17445-13 |
0,5mg
Oral
|
Tablet |
900
|
17,257
|
15,531,300
|
N1 |
Delpharm Poznań S.A.
Ba Lan
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Avodart
Dutasterid
- Strength / route
- 0,5mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Delpharm Poznań S.A. (Ba Lan)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-17445-13 |
0,5mg
Oral
|
Tablet |
0
|
17,257
|
0
|
N1 |
Delpharm Poznań S.A.
Ba Lan
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Azarga
Brinzolamid + timolol
- Strength / route
- 10mg/ml + 5mg/ml · Ophthalmic
- Qty
- 129 Vial
- Total
- 40,093,200
- Group
- N1
- Manufacturer
- Novartis Manufacturing NV (Belgium)
- Province / Facility
- Ho Chi Minh City · 79431
|
540110079123 |
10mg/ml + 5mg/ml
Ophthalmic
|
Vial |
129
|
310,800
|
40,093,200
|
N1 |
Novartis Manufacturing NV
Belgium
|
Ho Chi Minh City
79431
|
2026-11-05 |
|
Azopt
Brinzolamid
- Strength / route
- 10mg/ml · Ophthalmic
- Qty
- 193 Vial
- Total
- 22,517,117
- Group
- N1
- Manufacturer
- Alcon Research, LLC (United States)
- Province / Facility
- Ho Chi Minh City · 79431
|
001110009924 |
10mg/ml
Ophthalmic
|
Vial |
193
|
116,669
|
22,517,117
|
N1 |
Alcon Research, LLC
United States
|
Ho Chi Minh City
79431
|
2026-11-05 |
|
B12 Ankermann
Vitamin B12(Cyanocobalamin, Hydroxocobalamin)
- Strength / route
- 1000 mcg · Oral
- Qty
- 34,920 Tablet
- Total
- 244,440,000
- Group
- N1
- Manufacturer
- Manufacturing and batch release site: Artesan Pharma GmbH & Co. KG (Germany)
- Province / Facility
- Ho Chi Minh City · 79431
|
VN-22696-20 |
1000 mcg
Oral
|
Tablet |
34,920
|
7,000
|
244,440,000
|
N1 |
Manufacturing and batch release site: Artesan Pharma GmbH & Co. KG
Germany
|
Ho Chi Minh City
79431
|
2026-11-05 |
|
BIOFLORA 100MG
Saccharomyces boulardii
- Strength / route
- 100mg · Oral
- Qty
- 31,310 Sachet
- Total
- 172,205,000
- Group
- N1
- Manufacturer
- Biocodex (France)
- Province / Facility
- Ho Chi Minh City · 79431
|
VN-16392-13 |
100mg
Oral
|
Sachet |
31,310
|
5,500
|
172,205,000
|
N1 |
Biocodex
France
|
Ho Chi Minh City
79431
|
2026-11-05 |
|
Betaloc Zok 25mg
Metoprolol
- Strength / route
- 23,75mg · Oral
- Qty
- 16,800 Tablet
- Total
- 73,735,200
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-17243-13 |
23,75mg
Oral
|
Tablet |
16,800
|
4,389
|
73,735,200
|
N1 |
AstraZeneca AB
Sweden
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Betaloc Zok 25mg
Metoprolol
- Strength / route
- 23,75mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-17243-13 |
23,75mg
Oral
|
Tablet |
0
|
4,389
|
0
|
N1 |
AstraZeneca AB
Sweden
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Betaloc Zok 50mg
Metoprolol
- Strength / route
- 47.5mg (equivalent to 50mg metoprolol tartrate or 39mg metoprolol) · Oral
- Qty
- 11,200 Tablet
- Total
- 61,488,000
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Ho Chi Minh City · 79023
|
730110022123 |
47.5mg (equivalent to 50mg metoprolol tartrate or 39mg metoprolol)
Oral
|
Tablet |
11,200
|
5,490
|
61,488,000
|
N1 |
AstraZeneca AB
Sweden
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Betaloc Zok 50mg
Metoprolol
- Strength / route
- 47.5mg (equivalent to 50mg metoprolol tartrate or 39mg metoprolol) · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Ho Chi Minh City · 79044
|
730110022123 |
47.5mg (equivalent to 50mg metoprolol tartrate or 39mg metoprolol)
Oral
|
Tablet |
0
|
5,490
|
0
|
N1 |
AstraZeneca AB
Sweden
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Betaserc 24mg
Betahistin
- Strength / route
- 24mg · Oral
- Qty
- 6,000 Tablet
- Total
- 39,096,000
- Group
- N1
- Manufacturer
- Mylan Laboratories S.A.S (France)
- Province / Facility
- Ho Chi Minh City · 79023
|
300110779724 |
24mg
Oral
|
Tablet |
6,000
|
6,516
|
39,096,000
|
N1 |
Mylan Laboratories S.A.S
France
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Betaserc 24mg
Betahistin
- Strength / route
- 24mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Mylan Laboratories S.A.S (France)
- Province / Facility
- Ho Chi Minh City · 79044
|
300110779724 |
24mg
Oral
|
Tablet |
0
|
6,516
|
0
|
N1 |
Mylan Laboratories S.A.S
France
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Bidisamin 500
Glucosamin sulfat
- Strength / route
- 500mg · Oral
- Qty
- 15,000 Tablet
- Total
- 4,725,000
- Group
- N4
- Manufacturer
- Công ty Cổ phần Dược –Trang thiết bị Y tế Bình Định (Bidiphar) (Vietnam)
- Province / Facility
- Phu Yen · 54002
|
893100120825 |
500mg
Oral
|
Tablet |
15,000
|
315
|
4,725,000
|
N4 |
Công ty Cổ phần Dược –Trang thiết bị Y tế Bình Định (Bidiphar)
Vietnam
|
Phu Yen
54002
|
2026-11-05 |
|
Brilinta
Ticagrelor
- Strength / route
- 90mg · Oral
- Qty
- 9,900 Tablet
- Total
- 157,142,700
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-19006-15 |
90mg
Oral
|
Tablet |
9,900
|
15,873
|
157,142,700
|
N1 |
AstraZeneca AB
Sweden
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Brilinta
Ticagrelor
- Strength / route
- 90mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-19006-15 |
90mg
Oral
|
Tablet |
0
|
15,873
|
0
|
N1 |
AstraZeneca AB
Sweden
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Buscopan
Hyoscin butylbromid
- Strength / route
- 10mg · Oral
- Qty
- 13,000 Tablet
- Total
- 15,574,000
- Group
- N1
- Manufacturer
- Delpharm Reims (France)
- Province / Facility
- Ho Chi Minh City · 79023
|
300100131824 |
10mg
Oral
|
Tablet |
13,000
|
1,198
|
15,574,000
|
N1 |
Delpharm Reims
France
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Buscopan
Hyoscin butylbromid
- Strength / route
- 10mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Delpharm Reims (France)
- Province / Facility
- Ho Chi Minh City · 79044
|
300100131824 |
10mg
Oral
|
Tablet |
0
|
1,198
|
0
|
N1 |
Delpharm Reims
France
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Ceftriaxone 1g
Ceftriaxon
- Strength / route
- 1g · Injection
- Qty
- 3,000 Vial
- Total
- 17,670,000
- Group
- N4
- Manufacturer
- Minh Dan Pharmaceutical JSC (Vietnam)
- Province / Facility
- Binh Phuoc · 70008
|
893110889124 |
1g
Injection
|
Vial |
3,000
|
5,890
|
17,670,000
|
N4 |
Minh Dan Pharmaceutical JSC
Vietnam
|
Binh Phuoc
70008
|
2026-11-05 |
|
Celebrex
Celecoxib
- Strength / route
- 200mg · Oral
- Qty
- 12,000 Tablet
- Total
- 142,956,000
- Group
- N1
- Manufacturer
- Viatris Pharmaceuticals LLC; Packaging and batch release: Pfizer Manufacturing Deutschland GmbH (Manufacturing site: United States, Packaging and batch release: Germany)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-23247-22 |
200mg
Oral
|
Tablet |
12,000
|
11,913
|
142,956,000
|
N1 |
Viatris Pharmaceuticals LLC; Packaging and batch release: Pfizer Manufacturing Deutschland GmbH
Manufacturing site: United States, Packaging and batch release: Germany
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Celebrex
Celecoxib
- Strength / route
- 200mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Viatris Pharmaceuticals LLC; Packaging and batch release: Pfizer Manufacturing Deutschland GmbH (Manufacturing site: United States, Packaging and batch release: Germany)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-23247-22 |
200mg
Oral
|
Tablet |
0
|
11,913
|
0
|
N1 |
Viatris Pharmaceuticals LLC; Packaging and batch release: Pfizer Manufacturing Deutschland GmbH
Manufacturing site: United States, Packaging and batch release: Germany
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Cetraxal
Ciprofloxacin
- Strength / route
- 0,2% (w/v) · Auricular
- Qty
- 6,450 Ampoule
- Total
- 55,470,000
- Group
- N1
- Manufacturer
- Laboratorios Salvat, S.A (Spain)
- Province / Facility
- Ho Chi Minh City · 79431
|
840115525624 |
0,2% (w/v)
Auricular
|
Ampoule |
6,450
|
8,600
|
55,470,000
|
N1 |
Laboratorios Salvat, S.A
Spain
|
Ho Chi Minh City
79431
|
2026-11-05 |
|
Ciprobay 400mg
Ciprofloxacin
- Strength / route
- 400mg/200ml · Intravenous infusion
- Qty
- 1,000 Chai
- Total
- 254,838,000
- Group
- N1
- Manufacturer
- Bulk product manufacturing, primary and secondary packaging site: Fresenius Kabi Italia S.R.L; Batch release site: Bayer AG (Bulk product manufacturing, primary and secondary packaging site: Italy; Batch release site: Germany)
- Province / Facility
- Ho Chi Minh City · 79023
|
800115179723 |
400mg/200ml
Intravenous infusion
|
Chai |
1,000
|
254,838
|
254,838,000
|
N1 |
Bulk product manufacturing, primary and secondary packaging site: Fresenius Kabi Italia S.R.L; Batch release site: Bayer AG
Bulk product manufacturing, primary and secondary packaging site: Italy; Batch release site: Germany
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Ciprobay 400mg
Ciprofloxacin
- Strength / route
- 400mg/200ml · Intravenous infusion
- Qty
- 0 Chai
- Total
- 0
- Group
- N1
- Manufacturer
- Bulk product manufacturing, primary and secondary packaging site: Fresenius Kabi Italia S.R.L; Batch release site: Bayer AG (Bulk product manufacturing, primary and secondary packaging site: Italy; Batch release site: Germany)
- Province / Facility
- Ho Chi Minh City · 79044
|
800115179723 |
400mg/200ml
Intravenous infusion
|
Chai |
0
|
254,838
|
0
|
N1 |
Bulk product manufacturing, primary and secondary packaging site: Fresenius Kabi Italia S.R.L; Batch release site: Bayer AG
Bulk product manufacturing, primary and secondary packaging site: Italy; Batch release site: Germany
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Ciprobay 500
Ciprofloxacin
- Strength / route
- 500mg · Oral
- Qty
- 8,000 Tablet
- Total
- 105,792,000
- Group
- N1
- Manufacturer
- Bayer HealthCare Manufacturing S.r.l. (Italy)
- Province / Facility
- Ho Chi Minh City · 79023
|
800115179523 |
500mg
Oral
|
Tablet |
8,000
|
13,224
|
105,792,000
|
N1 |
Bayer HealthCare Manufacturing S.r.l.
Italy
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Ciprobay 500
Ciprofloxacin
- Strength / route
- 500mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Bayer HealthCare Manufacturing S.r.l. (Italy)
- Province / Facility
- Ho Chi Minh City · 79044
|
800115179523 |
500mg
Oral
|
Tablet |
0
|
13,224
|
0
|
N1 |
Bayer HealthCare Manufacturing S.r.l.
Italy
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Clopidogrel 75mg
Clopidogrel
- Strength / route
- 75mg · Oral
- Qty
- 40,000 Tablet
- Total
- 36,600,000
- Group
- N3
- Manufacturer
- OPV Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Tri · 45007
|
893110720724 |
75mg
Oral
|
Tablet |
40,000
|
915
|
36,600,000
|
N3 |
OPV Pharmaceutical JSC
Vietnam
|
Quang Tri
45007
|
2026-11-05 |
|
Co-Diovan 160/25
Valsartan + hydroclorothiazid
- Strength / route
- 160mg + 25mg · Oral
- Qty
- 4,200 Tablet
- Total
- 72,689,400
- Group
- N1
- Manufacturer
- Novartis Farma S.p.A. (Italy)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-19285-15 |
160mg + 25mg
Oral
|
Tablet |
4,200
|
17,307
|
72,689,400
|
N1 |
Novartis Farma S.p.A.
Italy
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Co-Diovan 160/25
Valsartan + hydroclorothiazid
- Strength / route
- 160mg + 25mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Novartis Farma S.p.A. (Italy)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-19285-15 |
160mg + 25mg
Oral
|
Tablet |
0
|
17,307
|
0
|
N1 |
Novartis Farma S.p.A.
Italy
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Co-Diovan 80/12,5
Valsartan + hydroclorothiazid
- Strength / route
- 80mg + 12,5mg · Oral
- Qty
- 5,600 Tablet
- Total
- 55,927,200
- Group
- N1
- Manufacturer
- Novartis Farma S.p.A. (Italy)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-19286-15 |
80mg + 12,5mg
Oral
|
Tablet |
5,600
|
9,987
|
55,927,200
|
N1 |
Novartis Farma S.p.A.
Italy
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Co-Diovan 80/12,5
Valsartan + hydroclorothiazid
- Strength / route
- 80mg + 12,5mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Novartis Farma S.p.A. (Italy)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-19286-15 |
80mg + 12,5mg
Oral
|
Tablet |
0
|
9,987
|
0
|
N1 |
Novartis Farma S.p.A.
Italy
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Combivent
Salbutamol + ipratropium
- Strength / route
- 0,500mg + 2,500mg · Aerosol inhalation
- Qty
- 2,500 Vial
- Total
- 40,185,000
- Group
- N1
- Manufacturer
- Laboratoire Unither (France)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-19797-16 |
0,500mg + 2,500mg
Aerosol inhalation
|
Vial |
2,500
|
16,074
|
40,185,000
|
N1 |
Laboratoire Unither
France
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Combivent
Salbutamol + ipratropium
- Strength / route
- 0,500mg + 2,500mg · Aerosol inhalation
- Qty
- 0 Vial
- Total
- 0
- Group
- N1
- Manufacturer
- Laboratoire Unither (France)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-19797-16 |
0,500mg + 2,500mg
Aerosol inhalation
|
Vial |
0
|
16,074
|
0
|
N1 |
Laboratoire Unither
France
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Coversyl 10mg
Perindopril
- Strength / route
- 10mg · Oral
- Qty
- 30,000 Tablet
- Total
- 212,520,000
- Group
- N1
- Manufacturer
- Les Laboratoires Servier Industrie (France)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-17086-13 |
10mg
Oral
|
Tablet |
30,000
|
7,084
|
212,520,000
|
N1 |
Les Laboratoires Servier Industrie
France
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Coversyl 10mg
Perindopril
- Strength / route
- 10mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Les Laboratoires Servier Industrie (France)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-17086-13 |
10mg
Oral
|
Tablet |
0
|
7,084
|
0
|
N1 |
Les Laboratoires Servier Industrie
France
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Coversyl 5mg
Perindopril
- Strength / route
- 5mg · Oral
- Qty
- 70,000 Tablet
- Total
- 351,960,000
- Group
- N1
- Manufacturer
- Les Laboratoires Servier Industrie (France)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-17087-13 |
5mg
Oral
|
Tablet |
70,000
|
5,028
|
351,960,000
|
N1 |
Les Laboratoires Servier Industrie
France
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Coversyl 5mg
Perindopril
- Strength / route
- 5mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Les Laboratoires Servier Industrie (France)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-17087-13 |
5mg
Oral
|
Tablet |
0
|
5,028
|
0
|
N1 |
Les Laboratoires Servier Industrie
France
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Crestor 10mg
Rosuvastatin
- Strength / route
- 10mg · Oral
- Qty
- 33,600 Tablet
- Total
- 332,505,600
- Group
- N1
- Manufacturer
- Manufacturing site: IPR Pharmaceuticals INC., Packaging site: AstraZeneca UK Limited (Manufacturing site: United States, Packaging site: United Kingdom)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-18150-14 |
10mg
Oral
|
Tablet |
33,600
|
9,896
|
332,505,600
|
N1 |
Manufacturing site: IPR Pharmaceuticals INC., Packaging site: AstraZeneca UK Limited
Manufacturing site: United States, Packaging site: United Kingdom
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Crestor 10mg
Rosuvastatin
- Strength / route
- 10mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Manufacturing site: IPR Pharmaceuticals INC., Packaging site: AstraZeneca UK Limited (Manufacturing site: United States, Packaging site: United Kingdom)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-18150-14 |
10mg
Oral
|
Tablet |
0
|
9,896
|
0
|
N1 |
Manufacturing site: IPR Pharmaceuticals INC., Packaging site: AstraZeneca UK Limited
Manufacturing site: United States, Packaging site: United Kingdom
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Crestor 20mg
Rosuvastatin
- Strength / route
- 20mg · Oral
- Qty
- 75,600 Tablet
- Total
- 1,126,666,800
- Group
- N1
- Manufacturer
- Manufacturing site: IPR Pharmaceuticals INC., Packaging site: AstraZeneca UK Limited (Manufacturing site: United States, Packaging site: United Kingdom)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-18151-14 |
20mg
Oral
|
Tablet |
75,600
|
14,903
|
1,126,666,800
|
N1 |
Manufacturing site: IPR Pharmaceuticals INC., Packaging site: AstraZeneca UK Limited
Manufacturing site: United States, Packaging site: United Kingdom
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Crestor 20mg
Rosuvastatin
- Strength / route
- 20mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Manufacturing site: IPR Pharmaceuticals INC., Packaging site: AstraZeneca UK Limited (Manufacturing site: United States, Packaging site: United Kingdom)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-18151-14 |
20mg
Oral
|
Tablet |
0
|
14,903
|
0
|
N1 |
Manufacturing site: IPR Pharmaceuticals INC., Packaging site: AstraZeneca UK Limited
Manufacturing site: United States, Packaging site: United Kingdom
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Daflon 500mg
Diosmin + hesperidin
- Strength / route
- 450mg; 50mg · Oral
- Qty
- 180,000 Tablet
- Total
- 699,480,000
- Group
- N1
- Manufacturer
- Les Laboratoires Servier Industrie (France)
- Province / Facility
- Ho Chi Minh City · 79023
|
300100032125 |
450mg; 50mg
Oral
|
Tablet |
180,000
|
3,886
|
699,480,000
|
N1 |
Les Laboratoires Servier Industrie
France
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Daflon 500mg
Diosmin + hesperidin
- Strength / route
- 450mg; 50mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Les Laboratoires Servier Industrie (France)
- Province / Facility
- Ho Chi Minh City · 79044
|
300100032125 |
450mg; 50mg
Oral
|
Tablet |
0
|
3,886
|
0
|
N1 |
Les Laboratoires Servier Industrie
France
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Dalacin C
Clindamycin
- Strength / route
- 300mg · Oral
- Qty
- 9,600 Tablet
- Total
- 108,220,800
- Group
- N1
- Manufacturer
- Fareva Amboise (France)
- Province / Facility
- Ho Chi Minh City · 79023
|
VN-18404-14 |
300mg
Oral
|
Tablet |
9,600
|
11,273
|
108,220,800
|
N1 |
Fareva Amboise
France
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Dalacin C
Clindamycin
- Strength / route
- 600 mg/4 ml · Injection
- Qty
- 600 Ampoule
- Total
- 62,880,000
- Group
- N1
- Manufacturer
- Pfizer Manufacturing Belgium NV (BỈ)
- Province / Facility
- Ho Chi Minh City · 79023
|
540110178323 |
600 mg/4 ml
Injection
|
Ampoule |
600
|
104,800
|
62,880,000
|
N1 |
Pfizer Manufacturing Belgium NV
BỈ
|
Ho Chi Minh City
79023
|
2026-11-05 |
|
Dalacin C
Clindamycin
- Strength / route
- 300mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Fareva Amboise (France)
- Province / Facility
- Ho Chi Minh City · 79044
|
VN-18404-14 |
300mg
Oral
|
Tablet |
0
|
11,273
|
0
|
N1 |
Fareva Amboise
France
|
Ho Chi Minh City
79044
|
2026-11-05 |
|
Dalacin C
Clindamycin
- Strength / route
- 600 mg/4 ml · Injection
- Qty
- 0 Ampoule
- Total
- 0
- Group
- N1
- Manufacturer
- Pfizer Manufacturing Belgium NV (BỈ)
- Province / Facility
- Ho Chi Minh City · 79044
|
540110178323 |
600 mg/4 ml
Injection
|
Ampoule |
0
|
104,800
|
0
|
N1 |
Pfizer Manufacturing Belgium NV
BỈ
|
Ho Chi Minh City
79044
|
2026-11-05 |